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Abstract 
Purpose: To investigate the effect of hydrazinocurcumin on a human vascular endothelial growth factor 
(VEGF)-induced corneal neovascularization in rabbit model. 
Methods: Murine corneal neovascularization (CorNV) was induced via two intrastromal implantations of 
VEGF polymer 2 mm from the limbus. Hydrazinocurcumin was administered topically on the cornea 4 
times daily for 7 days. The therapeutic effects of hydrazinocurcumin were evaluated daily using slit-
lamp. At the end of the treatment, the corneas were harvested for H&E staining, masson trichrome 
staining, immuno-histochemical study, and semi-quantification reverse transcription polymerase chain 
reaction (RT-PCR) was utilized for measurement of inflammation-related molecules. 
Results: Topical application of hydrazinocurcumin had significant therapeutic effects on CorNV 
Hydrazinocurcumin extract treatment was more effective in suppressing CorNV in terms of vessel length 
and levels of cluster of differentiation 31 (CD31) proteins or angiogenesis-related genes such as VEGF, 
matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (MMP9). The average length of 
vessels in hydrazinocurcumin-treated group was only 17 % of that in the control group. 
Hydrazinocurcumin also inhibited inflammation more markedly by more effectively inhibiting 
mononuclear and polymorphonuclear cell infiltration into the corneal stroma and reducing levels of 
stromal cell-derived factor-1 (SDF1), tumor necrosis factor-alpha (TNFα) and macrophage inflammatory 
protein-3 (MIP3a). In addition, the corneas of hydrazinocurcumin group had a more regular and 
compact architecture of collagen with thinner corneal thickness than those of the untreated group. 
Conclusion: Hydrazinocurcumin inhibited human vascular endothelial growth factor (VEGF)-induced 
rabbit corneal neovascularization and thus can potentially be used for its treatment. 
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Corneal neovascularization is found in 4.1 % of 
patients visiting general ophthalmology sections 
in the United States of America [1]. On 
penetration into the keratoplasty (PK) its 
treatment becomes difficult [2]. Angiogenesis, the 
process of new blood vessel formation by 
endothelial cells involve membrane degradation 
by proteolytic enzymes, chemotactic migration 
toward the stimulus, proliferation of these cells, 
and formation of vascular loops [3,4]. 
Angiogenesis has a crucial role for the growth 
and penetration of cancer cells. Therefore, many 
angiogenesis inhibitors of natural product origin 
have been developed by various research 
groups [5-7]. 
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Curcumin was isolated from the rhizome of 
Curcuma longa and is a promising 
chemopreventive agent presently in phase I 
clinical trials [8]. Curcumin exhibits anticancer 
activities against range of cancers including skin, 
fore stomach, duodenal, and colon 
carcinogenesis [9-12]. The anti-carcinogenic 
activity of curcumin is believed to be due to the 
inhibition of angiogenesis [13,14]. Study of 
structure-activity relationship for curcumin has 
led to the development of some more potent 
angiogenesis inhibitors like demethoxycurcumin 
(DC) and tetrahydrocurcumin (THC) [15]. It was 
demonstrated that aromatic ring of the phenol in 
curcuminoids and diketone moiety of THC play a 
vital role in the anti-oxidant activity [16,17]. 
Modification of the phenolic hydroxyl or methoxy 
groups resulted in the development of some 
analogs with potent activity as Phase 2 
detoxification enzymes and the inhibition of HIV-
1 integrase [18,19]. These findings revealed the 
importance of diketone moiety of curcumin in 
broad-range of biological activities. 
 
In the present study, the anti-angiogenic activity 
of the hydrazinocurcumin (HC), an analog of the 
curcumin was studied. Several angiogenesis 
assays including endothelial cell proliferation, 
chemo invasion, capillary tube formation, and in 
vivo angiogenesis of chorioal lantoic membrane 






Hydrazinocurcumin was obtained from Sigma (St 
Louis, MO, USA). 
 
Corneal neovascularization induction and 
treatment strategy 
 
All animal experiments were carried out following 
the guidelines of the Association for Research in 
Vision and Ophthalmology Statement for the Use 
of Animals in Ophthalmic and Vision Research. 
The study was approved (ref. no: 109/2014) by 
the Committee on the Ethics of Animal 
Experiments of the Affiliated Hospital of 
Academy of Military Medical Sciences, 
Shandong, China.  
 
Eight-week old female mice (Chengdu Dashuo 
Biological Technology Co., Ltd., Chengdu, 
China) were maintained according to the 
guidelines of the National Institute of Health and 
Academy of Military Medical Sciences for the 
Care and Use of Laboratory Animals. Under 
general anaesthesia with intraperitoneal 
ketamine and chlorpromazine, corneal 
neovascularization was induced through two 
intrastromal implantations of VEGF polymer 2 
mm from the limbus. Hydrazinocurcumin was 
administered topically on the corneas 4 times 
daily for 7 days. After completion of the treatment 
a slit lamp was used to take photograph and 
quantify CorNV using a method for determining 
corneal angiogenesis [17]. For additional studies 
the mice were sacrificed and their eyes were 
harvested. 
 
Histological studies  
 
For examination of histopathologic changes 
eyeballs were fixed with formalin and embedded 
with paraffin. The sections (3 µm) were analysed 
using haematoxylin and eosin and Masson’s 
trichrome stain. The eyeballs were snap-frozen in 
optimal cutting temperature (OCT, Sakura Fine 
technical, Tokyo, Japan) for immuno-
histochemical assay (IHC). Thin sections (5 µm) 
were fixed in ice-cold acetone for 10 min and 
subjected to conventional IHC protocols. The 
primary antibodies used were PE-conjugated 
anti-CD31 mAb (BD Pharmingen, CA, USA) 
mouse anti-SDF1 mAb (Santa Cruz, CA, USA). 
The secondary antibody used for SDF1 staining 
was rhodamine-conjugated goat anti-mouse IgG 
(Santa Cruz, CA, USA). The DAPI 
counterstained sections were examined using an 
Eclipse TE2000-U microscope (Nikon, Tokyo, 
Japan). 
 
Semi quantitative reverse transcription PCR  
 
The total RNA from deep frozen mouse corneas 
was extracted using a NucleoSpin RNA II kit 
(Macherey-Nagel, Germany). The PrimeScript 
RT Reagent Kit (Takara, Japan) was used to 
reverse transcribe first strand cDNA from the 1 
µg RNA. The primers for the genes of interest 
were subjected to PCR amplification. For PCR 
amplification denaturation was performed for 2 
minutes at 95 °C, followed by 35 cycles of 1 min 
at 95 °C, 30 s at 60 °C and 1 min at 72 °C with 
an additional extension for 10 min at 72 °C at the 
end. PCR products were resolved in 1.5 % 
agarose gel, stained with ethidium bromide, and 
photographed with a high-resolution digital 
camera under UV illumination. 
 
Statistical analysis  
 
All the data expressed are mean ± SD (n = 3). 
One way analysis of variance and SPSS 16.0 
software (SPSS, Inc., Chicago, IL, USA) were 
used for the analysis of differences in data. 
Differences were considered significant 
statistically at p < 0.05. 
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In vivo inhibitory effects of 
hydrazinocurcuminon CorNV  
 
The corneas of both the control and the 
treatment group of mice were examined carefully 
for penetration of the vessels from limbus.  The 
results showed penetration of vessels into the 
central cornea in case of the animals of control 
group by day 7 after induction of corneal 
neovascularization. However, topical 
administration of hydrazinocurcumin for 7 days, 
caused a significant inhibition of the development 
of corneal neovascularizationin the animals of 
the treatment group (Figure 1). The results from 
quantification statistics revealed that the average 
length of vessels in hydrazinocurcumin treated 




H & E staining of the corneas revealed the 
presence of vessels along with the infiltration of 
mononuclear and polymorphonuclear cells in the 
stromal layer in the mice of control group. On the 
other hand, the corneas of hydrazinocurcumin 
treated mice were found to contain very few new 
vessels. In addition, no infiltrating mononuclear 
and polymorphonuclear cells were observed 
(Figure 2). The results from masson trichrome 
staining revealed the presence of dispersed 
stroma layers and fluffier collagen fibers in the 
animals of the control group. However, the 
dispersed stroma layers and fluffier collagen 
fibers were absent in the hydrazinocurcumin 








        Figure 2: Histology of chemically burned corneas  
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Immunohistochemitry for CD31 and SDF1 
 
The control group of mice showed a significant 
immunoreactivity for CD31, suggesting the 
presence of large number of vessels in the 
corneas. However, the corneas of the 
hydrazinocurcumin treated mice exhibited very 
small immunoreactivity for CD31 (Figure 3). The 
lymphocyte chemoattractant cytokine, SDF-1 is 
known to be expressed significantly in the 
fibroblasts in cornea. However, the expression of 
SDF1 in the corneas of the animals treated with 
hydrazinocurcumin was found to be significantly 
lower than those of the control group (Figure 3). 
 
Inhibitory effects of hydrazinocurcumin on 
the expression of genes associated with 
angiogenesis or inflammation in burned 
cornea 
 
mRNA level of angiogenesis-related factors 
including VEGF, MMP2 and MMP9 was 
significantly decreased compared to the animals 
of the untreated group. Similarly the level of 
inflammation-related factors including SDF1, 
TNFα and MIP3a was also decreased 
significantly in hydrazinocurcumin treated mice 




    Figure 3: CD31and SDF1 expression profile in alkali burned mouse cornea 
 
 
Figure 4: Changes in angiogenesis- and 
inflammation-related genes in hydrazinocurcumin-





In order to maintain transparency for the purpose 
of refraction and transmission of light the cornea 
is an avascular tissue. However, infectious and 
inflammatory processes are reported to induce 
the growth of new vessels leading to corneal 
neovascularisation and finally scarring, edema, 
and blindness [3]. It is reported that corneal 
neovascularization occurs through the imbalance 
of angiogenic and anti-angiogenic protein factors. 
In vascularized human corneas a significant up-
regulation of vascular endothelial growth factor 
(VEGF), matrix metalloproteinase (MMP), and 
basic fibroblastic growth factor (bFGF) is 
observed [5]. 
 
In corneal neovascularization ocular surface 
develops inflammatory disorders therefore the 
control or prevention of inflammation may be 
employed for its treatment. It is reported that 
corneal neovascularization induced through two 
intrastromal implantations of VEGF polymer is 
associated with corneal inflammation and 
resembles inflammatory corneal diseases 
[20,21]. Therefore, corneal neovascularisation 
induced through two intrastromal implantations of 
VEGF polymer serves as a suitable animal 
model for the study of inflammatory corneal 
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neovascularization. There are a number of 
natural products known to possess anti-
angiogenic properties which include genistein 
[22], shark cartilage [23], curcumin [24,25], 
propolis extract [26] and AME [14-17]. 
 
The present study demonstrates that 
hydrazinocurcumin inhibits human vascular 
endothelial growth factor (VEGF)-induced rabbit 
corneal inflammation and corneal 
neovascularization significantly. Thus 
hydrazinocurcumin may be used for the 
treatment of corneal diseases involving 
neovascularization and inflammation. 
Hydrazinocurcumin was more effective in 
inhibiting corneal neovascularization at all levels, 
namely gross appearance, histological or cellular 




The results show that hydrazinocurcumin 
significantly inhibits inflammation and 
angiogenesis, and therefore, may have promise 
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